Air Travel for Subjects Receiving Long-Term Oxygen Therapy

References

1. 1.↵
   1. Adeloye D,
   2. Chua S,
   3. Lee C,
   4. Basquill C,
   5. Papana A,
   6. Theodoratou E,
   7. et al

   . Global and regional estimates of COPD prevalence: systematic review and meta-analysis. J Glob Health 2015;5(2):020415.
2. 2.↵
   1. Gendreau MA,
   2. DeJohn C

   . Responding to medical events during commercial airline flights. N Engl J Med 2002;346(14):1067–1073.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Ahmedzai S,
   2. Balfour-Lynn IM,
   3. Bewick T,
   4. Buchdahl R,
   5. Coker RK,
   6. Cummin AR,
   7. et al

   . Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax 2011;66(Suppl 1):i1–i30.

   OpenUrlFREE Full Text
4. 4.↵
   1. Schnell K,
   2. Weiss CO,
   3. Lee T,
   4. Krishnan JA,
   5. Leff B,
   6. Wolff JL,
   7. Boyd C

   . The prevalence of clinically-relevant comorbid conditions in patients with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008. BMC Pulm Med 2012;12:26.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. De Vries J,
   2. Seebregts A,
   3. Drent M

   . Assessing health status and quality of life in idiopathic pulmonary fibrosis: which measure should be used? Respir Med 2000;94(3):273–278.

   OpenUrlCrossRefPubMedWeb of Science
6. 6.↵
   1. Edvardsen A,
   2. Akerø A,
   3. Christensen CC,
   4. Ryg M,
   5. Skjønsberg OH

   . Air travel and chronic obstructive pulmonary disease: a new algorithm for pre-flight evaluation. Thorax 2012;67(11):964–969.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Chatila WM,
   2. Thomashow BM,
   3. Minai OA,
   4. Criner GJ,
   5. Make BJ

   . Comorbidities in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2008;5(4):549–555.

   OpenUrlCrossRefPubMed
8. 8.↵
   1. Hillas G,
   2. Perlikos F,
   3. Tsiligianni I,
   4. Tzanakis N

   . Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis 2015;10:95–109.

   OpenUrlPubMed
9. 9.↵
   1. Ahmadi Z,
   2. Sundh J,
   3. Bornefalk-Hermansson A,
   4. Ekström M

   . Long-term oxygen therapy 24 vs 15 h/day and mortality in chronic obstructive pulmonary disease. PLoS One 2016;11(9):e0163293.

   OpenUrl
10. 10.↵
    1. Franklin KA,
    2. Gustafson T,
    3. Ranstam J,
    4. Ström K

    . Survival and future need of long-term oxygen therapy for chronic obstructive pulmonary disease–gender differences. Respir Med 2007;101(7):1506–1511.

    OpenUrlCrossRefPubMedWeb of Science
11. 11.
    1. Cranston JM,
    2. Crockett AJ,
    3. Moss JR,
    4. Alpers JH

    . Domiciliary oxygen for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2005;(4):CD001744.
12. 12.
    1. Crockett AJ,
    2. Cranston JM,
    3. Moss JR,
    4. Alpers JH

    . Survival on long-term oxygen therapy in chronic airflow limitation: from evidence to outcomes in the routine clinical setting. Int Med J 2001;31(8):448–454.

    OpenUrlCrossRefWeb of Science
13. 13.
    1. Ekström MP,
    2. Wagner P,
    3. Ström KE

    . Trends in cause-specific mortality in oxygen-dependent chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011;183(8):1032–1036.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Ekström MP,
    2. Hermansson AB,
    3. Ström KE

    . Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187(7):715–720.

    OpenUrlCrossRefPubMedWeb of Science
15. 15.↵
    1. Rönmark EP,
    2. Ekerljung L,
    3. Lötvall J,
    4. Torén K,
    5. Rönmark E,
    6. Lundbäck B

    . Large scale questionnaire survey on respiratory health in Sweden: effects of late- and non-response. Respir Med 2009;103(12):1807–1815.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Reilly CC,
    2. Bausewein C,
    3. Pannell C,
    4. Moxham J,
    5. Jolley CJ,
    6. Higginson IJ

    . Patients' experiences of a new integrated breathlessness support service for patients with refractory breathlessness: results of a postal survey. Palliat Med 2016;30(3):313–322.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Long D,
    2. Deering B,
    3. Costello R

    . Travelling with oxygen. COPD Support Ireland 2017. January 13, 2017. http://copd.ie/living-with-copd/holidays-and-travel/travelling-with-oxygen/. Accessed November 12, 2017.
18. 18.↵
    ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: section for patients. European Respiratory Society 2004. http://www.ers-education.org/guidelines.aspx.
19. 19.↵
    1. Edvardsen A,
    2. Ryg M,
    3. Akerø A,
    4. Christensen CC,
    5. Skjønsberg OH

    . COPD and air travel: does hypoxia-altitude simulation testing predict in-flight respiratory symptoms? Eur Respir J 2013;42(5):1216–1223.

    OpenUrlAbstract/FREE Full Text
20. 20.↵
    1. Edvardsen A,
    2. Akero A,
    3. Hardie JA,
    4. Ryg M,
    5. Eagan TM,
    6. Skjønsberg OH,
    7. Bakke PS

    . High prevalence of respiratory symptoms during air travel in patients with COPD. Respir Med 2011;105(1):50–56.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    World Health Organization. Measuring quality of life. http://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/. Accessed November 12, 2017.
22. 22.↵
    1. Gallefoss F

    . The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Educ Couns 2004;52(3):259–266.

    OpenUrlCrossRefPubMedWeb of Science
23. 23.↵
    1. Walker J,
    2. Kelly PT,
    3. Beckert L

    . Airline policy for passengers requiring supplemental in-flight oxygen. Respirology 2009;14(4):589–594.

    OpenUrlCrossRefPubMedWeb of Science
24. 24.↵
    1. Cook JV,
    2. Dickinson HO,
    3. Eccles MP

    . Response rates in postal surveys of healthcare professionals between 1996 and 2005: an observational study. BMC Health Serv Res 2009;9:160.

    OpenUrlCrossRefPubMed
25. 25.↵
    International Air Transport Association. IATA air passenger forecast shows dip in long-term demand. November 26, 2015. http://www.iata.org/pressroom/pr/Pages/2015-11-26-01.aspx. Accessed November 12, 2017.